
JAGSNPHARMJagsonpal Pharmaceuticals Ltd.
Jagsonpal Pharmaceuticals Q2 FY27 Results: Consolidated Net Profit ₹12.29 Crore on Total Income of ₹184 Crore
Jagsonpal Pharmaceuticals (NSE: JAGSNPHARM) reported total income of ₹183.69 crore and net profit of ₹12.29 crore on a consolidated basis for the quarter ended 30 Sep 2026, it said in a filing on 28 Oct 2026. Standalone total income was ₹83.61 crore for the same quarter.
- Earnings
- pharmaceuticals